Forte Biosciences Inc (FBRX): What Are The Positives?
Forte Biosciences Inc (NASDAQ:FBRX) has a beta value of 2.94 and has seen 0.5 million shares traded in the recent trading session. The company, currently
Forte Biosciences Inc (NASDAQ:FBRX) has a beta value of 2.94 and has seen 0.5 million shares traded in the recent trading session. The company, currently
EVgo Inc (NASDAQ:EVGO) has a beta value of 2.39 and has seen 1.78 million shares traded in the recent trading session. The company, currently valued
Dell Technologies Inc (NYSE:DELL) has a beta value of 1.01 and has seen 1.27 million shares traded in the recent trading session. The company, currently
Rubrik Inc (NYSE:RBRK) has a beta value of 0.70 and has seen 2.04 million shares traded in the recent trading session. The company, currently valued
Atyr Pharma Inc (NASDAQ:ATYR) has a beta value of 0.90 and has seen 1.1 million shares traded in the recent trading session. The company, currently
Kyndryl Holdings Inc (NYSE:KD) has a beta value of 2.02 and has seen 1.22 million shares traded in the recent trading session. The company, currently
VYNE Therapeutics Inc (NASDAQ:VYNE) has a beta value of 1.60 and has seen 2.59 million shares traded in the recent trading session. The company, currently
Precision Biosciences Inc (NASDAQ:DTIL) has a beta value of 1.46 and has seen 7.48 million shares traded in the recent trading session. The company, currently
Plains All American Pipeline LP (NASDAQ:PAA) has a beta value of 0.66 and has seen 1.8 million shares traded in the recent trading session. The
Health In Tech Inc (NASDAQ:HIT) has seen 0.42 million shares traded in the recent trading session. The HIT stock price is -848.75% off its 52-week
© 2024, Powered by Smart TechOne